Spots Global Cancer Trial Database for basal cell carcinoma
Every month we try and update this database with for basal cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study | NCT06273722 | Basal Cell Carc... Optical Coheren... | Vivosight Multi... | 18 Years - | Maastricht University Medical Center | |
| Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) | NCT03646188 | Basal Cell Carc... | Placebo-contain... 25 µg doxorubic... 50 µg doxorubic... 100 µg doxorubi... 200 µg doxorubi... | 40 Years - | SkinJect, Inc. | |
| Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV) | NCT05340543 | Cutaneous Tumor Optical Coheren... Basal Cell Carc... Squamous Cell C... Melanoma | Confocal optica... | 18 Years - | Ramsay Générale de Santé | |
| AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma | NCT05817279 | Basal Cell Carc... Optical Coheren... | Optical coheren... | 18 Years - | Maastricht University Medical Center | |
| Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions | NCT02781389 | Basal Cell Carc... | 18 Years - | University Hospital, Essen | ||
| Electronic Brachytherapy for the Treatment of NMSC | NCT01016899 | Basal Cell Carc... Squamous Cell C... | electronic brac... | 50 Years - | Xoft, Inc. | |
| CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome | NCT04893486 | BCCs in Gorlin ... | PTX-022 Vehicle compara... | 18 Years - | Palvella Therapeutics, Inc. | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| DMSO-PDT of BCC - A 6 Year Follow up | NCT00218829 | Carcinoma, Basa... | 18 Years - | Norwegian University of Science and Technology | ||
| A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients | NCT00961896 | Treatment for B... | Vehicle LDE225 0.25% LDE225 0.75% | 18 Years - 75 Years | Novartis | |
| Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions | NCT01403480 | Basal Cell Carc... | 18 Years - | Rambam Health Care Campus | ||
| Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | NCT04928222 | Basal Cell Carc... | Doxorubicin-con... Placebo-contain... | 18 Years - 75 Years | SkinJect, Inc. | |
| Nevoid Basal Cell Carcinomas in Gorlin Syndrome | NCT05898347 | Basal Cell Carc... Gorlin Syndrome | Active surveill... | 6 Years - 17 Years | Oslo University Hospital | |
| Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma | NCT03889912 | Cutaneous Squam... Basal Cell Carc... | Cemiplimab | 18 Years - | Regeneron Pharmaceuticals | |
| Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma | NCT06252857 | Basal Cell Carc... | Imiquimod Topic... | 18 Years - | Maastricht University Medical Center | |
| Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma | NCT01015898 | Basal Cell Carc... | photodynamic th... | 18 Years - | Shahid Beheshti University of Medical Sciences | |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) | NCT03208296 | Basal Cell Carc... | ASN-002 | 18 Years - | Ascend Biopharmaceuticals Ltd | |
| BCC Excision Revisited | NCT05853315 | Basal Cell Carc... Eye Diseases Eye Cancer | Surgery | - | Medical University of Vienna | |
| Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery | NCT01298167 | Basal Cell Carc... Squamous Cell C... | Cyanoacrylate t... | 18 Years - | Yale University | |
| Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. | NCT00049959 | Basal Cell Carc... Nevoid Basal Ce... Gorlin Syndrome | verteporfin PDT | 18 Years - 90 Years | QLT Inc. | |
| An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC | NCT04155190 | Recurrent Basal... | Patidegib Topic... Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. | |
| DERM US and EU Validation Study | NCT05126173 | Malignant Skin ... Basal Cell Carc... Squamous Cell C... | Deep Ensemble f... | 18 Years - | Skin Analytics Limited | |
| Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina | NCT02438644 | Basal Cell Carc... | - | Hoffmann-La Roche | ||
| Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors. | NCT05072327 | Eyelid Tumor | Mohs surgery cryotherapy | - | Sun Yat-sen University | |
| Basal Cell Carcinoma Recurrence After Mohs Surgery | NCT00882791 | Basal Cell Carc... | 18 Years - | Northwestern University | ||
| Reflectance Confocal Microscopy in Basal Cell Carcinoma | NCT02623101 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Radboud University Medical Center | |
| The Impact of Total Body Skin Examination on Skin Cancer Detection | NCT00765193 | Melanoma Basal Cell Carc... Squamous Cell C... Merkel Cell Car... Skin Cancer | Inspection of c... | 18 Years - 95 Years | Medical University of Graz | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | NCT04534127 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) | NCT00581425 | Basal Cell Carc... | Imiquimod and I... | - | The University of Texas Health Science Center, Houston | |
| Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas | NCT01556009 | Basal Cell Nevu... Gorlin's Syndro... | Vismodegib Aminolevulinic ... | 18 Years - 75 Years | UCSF Benioff Children's Hospital Oakland | |
| Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer | NCT01463709 | Basal Cell Carc... | PulseCure pulse... | 18 Years - 75 Years | UCSF Benioff Children's Hospital Oakland | |
| Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | NCT04540588 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma | NCT06150144 | Basal Cell Carc... BCC | 5-Fluorouracil SURGERY | - | University of Aleppo | |
| Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms | NCT05402046 | Melanoma (Skin) Nevus Nevus, Spitz Nevus Halo Nevus, Pigmente... Basal Cell Carc... Squamous Cell C... Bowen's Disease Melanoma in Sit... Spot Pigmented | Mobile phone ap... | 18 Years - | MelanomaPRO, Russia | |
| Pilot Study of PDL to Treat BCC and SCCIS | NCT01245972 | Basal Cell Carc... Squamous Cell C... | PDL Treatment | 18 Years - | University of California, San Diego | |
| Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes | NCT01700049 | Basal Cell Carc... | vismodegib (150... | 18 Years - | Mayo Clinic | |
| Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma | NCT04552990 | BCC BCC - Basal Cel... Basal Cell Carc... Basal Cell Canc... Superficial Bas... Nodular Basal C... | Jet injection o... Surgical excisi... Illumination Incubation | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins | NCT01872130 | Basal Cell Carc... Squamous Cell C... | 18 Years - | Memorial Sloan Kettering Cancer Center | ||
| Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients | NCT02762084 | Basal Cell Nevu... | Patidegib Vehicle gel | 18 Years - 85 Years | PellePharm, Inc. | |
| CemiplimAb Survivorship Epidemiology | NCT03836105 | Cutaneous Squam... Basal Cell Carc... | cemiplimab | 18 Years - | Regeneron Pharmaceuticals | |
| D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study | NCT06273722 | Basal Cell Carc... Optical Coheren... | Vivosight Multi... | 18 Years - | Maastricht University Medical Center | |
| Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery | NCT01212562 | Basal Cell Carc... | Immunocryosurge... | 18 Years - | University of Ioannina | |
| Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes | NCT01700049 | Basal Cell Carc... | vismodegib (150... | 18 Years - | Mayo Clinic | |
| Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors | NCT00449358 | Basal Cell Carc... | apply methyl-AL... | 18 Years - | Assuta Hospital Systems | |
| Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy | NCT01265472 | Squamous Cell C... Basal Cell Carc... | - | Rambam Health Care Campus | ||
| An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC | NCT04155190 | Recurrent Basal... | Patidegib Topic... Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. | |
| Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma | NCT05041777 | Basal Cell Carc... Optical Coheren... Deep Learning Artificial Inte... | Optical Coheren... | 18 Years - | Maastricht University Medical Center | |
| Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma | NCT03467789 | Basal Cell Carc... Basal Cell Nevu... | Dietary Vitamin... Photodynamic th... Serum Maintenan... | - | Case Comprehensive Cancer Center | |
| Pilot Study of PDL to Treat BCC and SCCIS | NCT01245972 | Basal Cell Carc... Squamous Cell C... | PDL Treatment | 18 Years - | University of California, San Diego | |
| Video-Based Treatment Options for Basal Cell Carcinoma | NCT02158650 | Basal Cell Carc... | Video-Based Inf... | 18 Years - | Emory University | |
| Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | NCT03070691 | Basal Cell Carc... | LDE225B Vehicle | 18 Years - | Novartis | |
| Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery | NCT03610620 | Basal Cell Carc... | Vivascope 2500 ... | 18 Years - | Norfolk and Norwich University Hospitals NHS Foundation Trust | |
| Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma | NCT04744935 | Basal Cell Carc... Superficial Bas... Nodular Basal C... | 1064 nm long-pu... | 18 Years - 99 Years | University of California, Irvine | |
| Spectral Diagnosis of Cutaneous Malignancy | NCT00476905 | Skin Cancer | Spectral Diagno... | 18 Years - | M.D. Anderson Cancer Center | |
| Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation | NCT04795297 | Basal Cell Carc... | 16 Years - 99 Years | University Hospital, Montpellier | ||
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo | NCT02902822 | Erysipelas Impetigo Herpes Zoster Molluscum Conta... Warts Tinea Melanoma Actinic Keratos... Basal Cell Carc... Squamous Cell C... | Screening Tele-dermatolog... | 18 Years - 99 Years | Centro Studi Gised | |
| HIFU for Treatment of Non-nodular and Recurrent BCC | NCT05133427 | Carcinoma, Basa... | TOOsonix system... | 18 Years - | Bispebjerg Hospital | |
| Remote Assessment of OCT Scans for BCC Detection | NCT06273709 | Basal Cell Carc... | Vivosight Multi... | 18 Years - | Maastricht University Medical Center | |
| A Beta-only IL-2 ImmunoTherapY Study | NCT05086692 | Advanced Solid ... Unresectable So... Clear Cell Rena... Triple Negative... Non-Small Cell ... Non-Small Cell ... Colorectal Canc... Gastric Cancer Cervical Cancer Basal Cell Carc... Bladder Cancer Merkel Cell Car... Squamous Cell C... Cutaneous Squam... Pleural Mesothe... Esophageal Canc... Endometrial Car... Solid Tumor Solid Tumor, Ad... MSI-H Solid Mal... Cancer With A H... Epithelial Ovar... Primary Periton... Gastroesophagea... Acral Melanoma Mucosal Melanom... Cutaneous Melan... DMMR Solid Mali... Fallopian Tube ... Ovarian Cancer MSI-H Cancer DMMR Cancer Pancreas Adenoc... Skin Cancer | MDNA11 Pembrolizumab | 18 Years - | Medicenna Therapeutics, Inc. | |
| R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors | NCT06398418 | Melanoma Basal Cell Carc... Squamous Cell C... Melanoma Recurr... Basal Cell Canc... Squamous Cell C... | R-5780 | 18 Years - 80 Years | Rise Therapeutics LLC | |
| Using MC1R Genotype to Impact Melanoma Risk Behavior | NCT03509467 | Melanoma (Skin) Squamous Cell C... Squamous Cell C... Skin Cancer Basal Cell Carc... Basal Cell Canc... | Personalized In... Standard Inform... DNA Extraction ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| T-VEC in Non-melanoma Skin Cancer | NCT03458117 | Non-melanoma Sk... Basal Cell Carc... Squamous Cell C... Cutaneous Lymph... Merkel Cell Car... | Talimogene Lahe... | 18 Years - | University of Zurich | |
| Using MC1R Genotype to Impact Melanoma Risk Behavior | NCT03509467 | Melanoma (Skin) Squamous Cell C... Squamous Cell C... Skin Cancer Basal Cell Carc... Basal Cell Canc... | Personalized In... Standard Inform... DNA Extraction ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors | NCT03734913 | Basal Cell Carc... Medulloblastoma Adenocarcinoma ... Small Cell Lung... Neuroendocrine ... Glioblastoma | ZSP1602 | 18 Years - 75 Years | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | |
| Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) | NCT04308395 | Basal Cell Nevu... | Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. | |
| Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma | NCT05188729 | Basal Cell Carc... Skin Cancer Cancer of the S... Cancer of the S... Carcinoma | LTX-315 Part 1 VP-315 Part 2 | 18 Years - | Verrica Pharmaceuticals Inc. | |
| A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma | NCT03534947 | Basal Cell Carc... Basal Cell Carc... Skin Cancer Invasive Carcin... | Sonidegib Imiquimod Surgery Best supportive... | 18 Years - | Melanoma Institute Australia | |
| Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo | NCT00574392 | Basal Cell Carc... Melanoma Non-Malignant S... Squamous Cell C... | Multiwavelength... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. | NCT00601185 | Basal Cell Carc... Melanoma Squamous Cell C... Non-Malignant S... | confocal micros... | 18 Years - 80 Years | Memorial Sloan Kettering Cancer Center | |
| Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma | NCT00985829 | Basal Cell Carc... | photodynamic th... | 18 Years - | Shahid Beheshti University of Medical Sciences | |
| Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas | NCT01903239 | Basal Cell Carc... | Low-Risk BCC Ex... | - | Thomas Jefferson University | |
| Video-Based Treatment Options for Basal Cell Carcinoma | NCT02158650 | Basal Cell Carc... | Video-Based Inf... | 18 Years - | Emory University | |
| Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma | NCT00985829 | Basal Cell Carc... | photodynamic th... | 18 Years - | Shahid Beheshti University of Medical Sciences | |
| Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic Keratosis | NCT05202860 | Actinic Keratos... Basal Cell Carc... Squamous Cell C... | HPV Vaccine PLACEBO vaccine | 18 Years - | Bispebjerg Hospital | |
| Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. | NCT00049959 | Basal Cell Carc... Nevoid Basal Ce... Gorlin Syndrome | verteporfin PDT | 18 Years - 90 Years | QLT Inc. | |
| Vismodegib for Treatment of Basal Cell Carcinoma | NCT01543581 | Basal Cell Carc... | Vismodegib Placebo | 18 Years - | Loma Linda University | |
| Electronic Brachytherapy for the Treatment of NMSC | NCT01016899 | Basal Cell Carc... Squamous Cell C... | electronic brac... | 50 Years - | Xoft, Inc. | |
| Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) | NCT00581425 | Basal Cell Carc... | Imiquimod and I... | - | The University of Texas Health Science Center, Houston | |
| Fast Track Diagnosis of Skin Cancer by Advanced Imaging | NCT04229277 | Malignant Melan... Nevus, Pigmente... Basal Cell Carc... Seborrheic Kera... | optical coheren... | 18 Years - | University Hospital Bispebjerg and Frederiksberg |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
